Advertisement

Fetale Infektionen

  • Matthias Meyer-Wittkopf
Chapter

Zusammenfassung

Trotz aller Fortschritte in der Ultraschalltechnologie resultieren die Verbesserungen der fetalen Infektionsdiagnostik vor allem aus den innovativen serologischen und molekulargenetischen Labormethoden. Diese Neuerungen haben die pränatalen diagnostischen und therapeutischen Strategien in den letzten zwei Jahrzehnten erheblich beeinflusst und ermöglichen in Kenntnis der unterschiedlichen Sensitivitäten und Spezifitäten der jeweiligen Labornachweismethoden (PCR, Viruskultur, etc.) aus Fruchtwasser, fetalem Aszites oder fetalen Pleuraergüssen zunehmend risikoärmere fetal-invasive Verfahren mit nur noch selten erforderlichen direkten fetalen Blutentnahmen (Banatvala u. Brown 2004, Benoist et al. 2008, Bonvicini et al. 2009, Enders et al. 2010, Goegebuer et al. 2009, Groß et al. 2001, Guerra et al. 2008, Montoya u. Remington 2008, Signorell et al. 2006, Syridou et al. 2008, Wandinger et al. 2011, Tab. 25.1).

Literatur

  1. Adler SP, Nigro G (2009) Findings and conclusions from CMV hyperimmune globulin treatment trials. J Clin Virol 46(Suppl 4):S54–S57CrossRefPubMedGoogle Scholar
  2. Banatvala JE, Brown DW (2004) Rubella. Lancet 363(9415):1127–1137CrossRefPubMedGoogle Scholar
  3. Bekhit MT, Greenwood PA, Warren R, Aarons E, Jauniaux E (2009) In utero treatment of severe fetal anaemia due to parvovirus B19 in one fetus in a twin pregnancy – a case report and literature review. Fetal Diagn Ther 25(1):153–157CrossRefPubMedGoogle Scholar
  4. Benoist G, Salomon LJ, Jacquemard F, Daffos F, Ville Y (2008) The prognostic value of ultrasound abnormalities and biological parameters in blood of fetuses infected with cytomegalovirus. BJOG Jun 115(7):823–829CrossRefGoogle Scholar
  5. Benoist G, Leruez-Ville M, Magny JF, Jacquemard F, Salomon LJ, Ville Y (2013) Management of Pregnancies with Confirmed Cytomegalovirus Fetal Infection. Fetal Diagn Ther 33:203–214CrossRefPubMedGoogle Scholar
  6. Bessières MH, Berrebi A, Cassaing S, Fillaux J, Cambus JP, Berry A, Assouline C, Ayoubi JM, Magnaval JF (2009) Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis. Mem Inst Oswaldo Cruz 104(2):389-392CrossRefPubMedGoogle Scholar
  7. Best JM, O’Shea S, Tipples G, Davies N, Al-Khusaiby SM, Krause A, Hesketh LM, Jin L, Enders G (2002) Interpretation of rubella serology in pregnancy – pitfalls and problems. BMJ 325:147–148CrossRefPubMedPubMedCentralGoogle Scholar
  8. Bonvicini F, Manaresi E, Gallinella G, Gentilomi GA, Musiani M, Zerbini M (2009) Diagnosis of fetal parvovirus B19 infection: value of virological assays in fetal specimens. BJOG 116(6):813–817CrossRefPubMedGoogle Scholar
  9. Cannon MJ, Schmid DS, Hyde TB (2010) Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 20(4):202–213CrossRefPubMedGoogle Scholar
  10. Cheeran MC, Lokensgard JR, Schleiss MR (2009) Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev 22(1):99–126CrossRefPubMedPubMedCentralGoogle Scholar
  11. Christoph J, Kattner E, Seitz HM, Reiter-Owona I (2004) Strategies for the diagnosis and treatment of prenatal toxoplasmosis – a survey. Z Geburtshilfe Neonatol 208:10–16CrossRefPubMedGoogle Scholar
  12. Coll O, Benoist G, Ville Y, Weisman LE, Botet F, Anceschi MM, Greenough A, Gibbs RS, Carbonell-Estrany X (2009) Guidelines on CMV congenital infection. J Perinat Med 37(5):433–445CrossRefPubMedGoogle Scholar
  13. Enders G, Calm A, Schaub J (1984) Rubella embryopathy after previous maternal rubella vaccination Infection. Mar–Apr 12(2):96–8Google Scholar
  14. Enders G, Daiminger A, Bäder U, Exler S, Enders M (2011) Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. J Clin Virol 52(3):244-246CrossRefPubMedGoogle Scholar
  15. Enders M, Klingel K, Weidner A, Baisch C, Kandolf R, Schalasta G, Enders G (2010) Risk of fetal hydrops and non-hydropic late intrauterine fetal death after gestational parvovirus B19 infection. J Clin Virol 49(3):163–168CrossRefPubMedGoogle Scholar
  16. Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M. (1994) Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet.18;343(8912):1548-51CrossRefGoogle Scholar
  17. Enders M, Weidner A, Zoellner I, Searle K, Enders G (2004) Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn 24(7):513–518CrossRefPubMedGoogle Scholar
  18. Enders G (2005) Akzidentelle Rötelnschutzimpfungen um den Zeitpunkt der Konzeption und in der Frühschwangerschaft Bundesgesundheitsblatt–Gesundheitsforschung–Gesundheitsschutz. Springer Medizin Verlag, BerlinGoogle Scholar
  19. Foulon W, Pinon JM, Stray-Pedersen B, Pollak A, Lappalainen M, Decoster A, Villena I, Jenum PA, Hayde M, Naessens A (1999) Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters. Am J Obstet Gynecol 181(4):843-847CrossRefPubMedGoogle Scholar
  20. Gärtner B, Enders M, Luft-Duchow C, Bocharov G, Modorow S (2007) Parvovirus-B19-Infektionen bei Schwangeren in der Kinderbetreuung Bundesgesundheitsblatt – Gesundheitsforschung – Gesundheitsschutz 50: 1369. Springer Medizin Verlag, BerlinGoogle Scholar
  21. Goegebuer T, Van Meensel B, Beuselinck K, Cossey V, Van Ranst M, Hanssens M, Lagrou K (2009) Clinical predictive value of real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples. J Clin Microbiol 47(3):660–665CrossRefPubMedGoogle Scholar
  22. Groß U (2004) Prävalenz und Public-Health-Aspekte der Toxoplasmose. Bundesgesundheitsblatt 47:692–697Google Scholar
  23. Groß U, Roos T, Friese K (2001) Toxoplasmose in der Schwangerschaft. Dt Ärzteblatt 98:A 3293–A 3300Google Scholar
  24. Guerra B, Simonazzi G, Puccetti C, Lanari M, Farina A, Lazzarotto T, Rizzo N (2008) Ultrasound prediction of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol 198:380.e1–380.e7CrossRefGoogle Scholar
  25. Hamprecht K, Jahn G (2007) Human cytomegalovirus and congenital virus infection. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 50(11):1379–1392CrossRefPubMedGoogle Scholar
  26. Hamprecht K, Maschmann J, Jahn G, Poets CF, Goelz R (2008) Cytomegalovirus transmission to preterm infants during lactation. J Clin Virol 41(3):198–205CrossRefPubMedGoogle Scholar
  27. Hohlfeld P, Daffos F, Costa JM, Thulliez P, Forestier F, Vidaud M (1994) Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med 331:695–699CrossRefPubMedGoogle Scholar
  28. Kakoulidou M, Forsgren M, Lewensohn-Fuchs I, Johansen K (2010) Serum levels of rubella-specific antibodies in Swedish women following three decades of vaccination programmes. Vaccine 28(4):1002–1007CrossRefPubMedGoogle Scholar
  29. Lamont RF, Sobel JD, Vaisbuch EB, Kusanovic JP, Mazaki-Tovi S, Kim SK, Uldbjerg N, Romero R (2011) Parvovirus B19 infection in human pregnancy. BJOG 118:175–186CrossRefPubMedGoogle Scholar
  30. Lazzarotto T, Guerra B, Lanari M, Gabrielli L, Landini MP (2008) New advances in the diagnosis of congenital cytomegalovirus infection. J Clin Virol 41(3):192–197CrossRefPubMedGoogle Scholar
  31. Montoya JG, Remington JS (2008) Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis 47(4):554–566CrossRefPubMedGoogle Scholar
  32. Munro ND, Sheppard S, Smithells RW, Holzel H, Jones G (1987) Temporal relations between maternal rubella and congenital defects. Lancet 2(8552):201–204CrossRefPubMedGoogle Scholar
  33. Mylonas I, Gutsche S, Anton G, Jeschke U, Weissenbacher ER, Friese K (2007) Parvovirus-B19-Infektion in der Schwangerschaft. Z Geburtsh Neonatol 211:60–68CrossRefGoogle Scholar
  34. Nagel HT, de Haan TR, Vandenbussche FP, Oepkes D, Walther FJ (2007) Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection. Obstet Gynecol 109(1):42–47CrossRefPubMedGoogle Scholar
  35. Nigro G, Adler SP, La Torre R, Best AM (2005) Passive immunization during pregnancy for congenital cytomegalovirus infection. Congenital Cytomegalovirus Collaborating Group. N Engl J Med 353(13):1350–1362CrossRefPubMedGoogle Scholar
  36. Nigro G, Torre RL, Pentimalli H, Taverna P, Lituania M, de Tejada BM, Adler SP (2008) Regression of fetal cerebral abnormalities by primary cytomegalovirus infection following hyperimmunoglobulin therapy. Prenat Diagn 28(6):512–517CrossRefPubMedGoogle Scholar
  37. Pass RF, Zhang C, Evans A, Simpson T, Andrews W, Huang ML, Corey L, Hill J, Davis E, Flanigan C, Cloud G (2009) Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med 360(12):1191–1199CrossRefPubMedPubMedCentralGoogle Scholar
  38. Picone O, Simon I, Benachi A, Brunelle F, Sonigo P (2008) Comparison between ultrasound and magnetic resonance imaging in assessment of fetal cytomegalovirus infection. Prenat Diagn 28(8):753–758CrossRefPubMedGoogle Scholar
  39. Pratlong F, Boulot P, Villena I, Issert E, Tamby I, Cazenave J, Dedet JP (1996) Antenatal diagnosis of congenital toxoplasmosis: evaluation of the biological parameters in a cohort of 286 patients. Br J Obstet Gynaecol 103(6):552-557CrossRefPubMedGoogle Scholar
  40. Pretlove SJ, Fox CE, Khan KS, Kilby MD (2009) Noninvasive methods of detecting fetal anaemia: a systematic review and meta-analysis. BJOG 116(12):1558–1567CrossRefPubMedGoogle Scholar
  41. Romand S, Wallon M, Franck J, Thulliez P, Peyron F, Dumon H (2001) Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. Obstet Gynecol 97(2):296-300PubMedGoogle Scholar
  42. Sanchez MA, Bello-Munoz JC, Cebrecos I, Sanz TH, Martinez JS, Moratonas EC, Roura LC (2011) The prevalence of congenital varicella syndrome after a maternal infection, but before 20 weeks of pregnancy: a prospective cohort study. J Matern Fetal Neonatal Med 24(2):341–347CrossRefPubMedGoogle Scholar
  43. Shields KE, Galil K, Seward J, Sharrar RG, Cordero JF, Slater E (2001) Varicella vaccine exposure during pregnancy: data from the first 5 years of the pregnancy registry. Obstet Gynecol 98(1):14–19PubMedGoogle Scholar
  44. Signorell LM, Seitz D, Merkel S, Berger R, Rudin C (2006) Cord blood screening for congenital toxoplasmosis in northwestern Switzerland, 1982–1999. Pediatr Infect Dis J 25(2):123–128CrossRefPubMedGoogle Scholar
  45. Stelma FF, Smismans A, Goossens VJ, Bruggeman CA, Hoebe CJ (2009) Occupational risk of human Cytomegalovirus and Parvovirus B19 infection in female day care personnel in the Netherlands a study based on seroprevalence. Eur J Clin Microbiol Infect Dis 28(4):393–397CrossRefPubMedGoogle Scholar
  46. Syridou G, Spanakis N, Konstantinidou A, Piperaki ET, Kafetzis D, Patsouris E, Antsaklis A, Tsakris A (2008) Detection of cytomegalovirus, parvovirus B19 and herpes simplex viruses in cases of intrauterine fetal death: association with pathological findings. J Med Virol 80(10):1776–1782CrossRefPubMedGoogle Scholar
  47. Thiébaut R, Leproust S, Chêne G, Gilbert R, SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group (2007) Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients’ data. Lancet 369(9556):115–122CrossRefPubMedGoogle Scholar
  48. Ushida M, Katow S, Furukawa S (2003) Congenital rubella syndrome due to infection after maternal antibody conversion with vaccine. Jpn J Infect Dis 56(2):68–69PubMedGoogle Scholar
  49. Vauloup-Fellous C, Hübschen JM, Abernathy ES, Icenogle J, Gaidot N, Dubreuil P, Parent-du-Châtelet I, Grangeot-Keros L, Muller CP (2010) Phylogenetic analysis of rubella viruses involved in congenital rubella infections in France between 1995 and 2009. J Clin Microbiol 48(7):2530–2535CrossRefPubMedPubMedCentralGoogle Scholar
  50. Vauloup-Fellous C, Picone O, Cordier AG, Parent-du-Châtelet I, Senat MV, Frydman R, Grangeot-Keros L (2009) Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital. J Clin Virol 46(Suppl 4):S49–S53CrossRefPubMedGoogle Scholar
  51. Verstraelen H, Vanzieleghem B, Defoort P, Vanhaesebrouck P, Temmerman M (2003) Prenatal ultrasound and magnetic resonance imaging in fetal varicella syndrome: correlation with pathology findings. Prenat Diagn 23(9):705–709CrossRefPubMedGoogle Scholar
  52. Villena I, Ancelle T, Delmas C, Garcia P, Brezin AP, Thulliez P, Wallon M, King L, Goulet V (2010) Toxosurv network and National Reference Centre for Toxoplasmosis.Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro Surveill. Jun 24 15(25). pii: 19600Google Scholar
  53. Wallon M, Franck J, Thulliez P, Huissoud C, Peyron F, Garcia-Meric P, Kieffer F (2010) Accuracy of real-time polymerase chain reaction for Toxoplasma gondii in amniotic fluid. Obstet Gynecol 115(4):727-733CrossRefPubMedGoogle Scholar
  54. Wandinger KP, Saschenbrecker S, Steinhagen K, Scheper T, Meyer W, Bartelt U, Enders G (2011) Diagnosis of recent primary rubella virus infections: Significance of glycoprotein-based IgM serology, IgG avidity and immunoblot analysis. J Virol Methods 174(1-2):85–93CrossRefPubMedGoogle Scholar
  55. Wutzler P, Sauerbrei A (2007) Varizellen in der Schwangerschaft und bei Neugeborenen. Bundesgesundheitsblatt – Gesundheitsforschung – Gesundheitsschutz 50:237–244 (Springer Medizin Verlag)CrossRefPubMedGoogle Scholar
  56. Yamamoto AY, Mussi-Pinhata MM, Boppana SB, Novak Z, Wagatsuma VM, Oliveira Pde F, Duarte G, Britt WJ (2010) Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population. Am J Obstet Gynecol 202(3):297.e1–297.e8CrossRefGoogle Scholar
  57. Yinon Y, Farine D, Yudin MH, Gagnon R, Hudon L, Basso M, Bos H, Delisle MF, Menticoglou S, Mundle W, Ouellet A, Pressey T, Roggensack A, Boucher M, Castillo E, Gruslin A, Money DM, Murphy K, Ogilvie G, Paquet C, Van Eyk N, van Schalkwyk J (2010) Cytomegalovirus infection in pregnancy. Fetal Medicine Committee, Society of Obstetricians and Gynaecologists of Canada. J Obstet Gynaecol Can 32(4):348–354CrossRefPubMedGoogle Scholar
  58. Zalel Y, Gilboa Y, Berkenshtat M, Yoeli R, Auslander R, Achiron R, Goldberg Y (2008) Secondary cytomegalovirus infection can cause severe fetal sequelae despite maternal preconceptional immunity. Ultrasound Obstet Gynecol 31(4):417–420CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Matthias Meyer-Wittkopf
    • 1
  1. 1.Zentrum für Ultraschall- und PränataldiagnostikMathias-Spital RheineRheineDeutschland

Personalised recommendations